In an interview with The Edge Singapore in December 2024, founder and CEO Ravi Sajwan did not rule out the possibility of going public.
UltraGreen.ai has secured US$188 million ($240.91 million) from a group of investors led by Temasek-linked 65 Equity Partners and also Vitruvian Partners and August Global Partners, valuing the medical company at US$1.3 billion.
UltraGreen, which describes itself as a global leader in fluorescence-guided surgical technologies and precision healthcare solutions, says the funding will help support its next growth phase.
